AstraZeneca, breast cancer
AstraZeneca drug fails to extend lives of breast cancer patients
A new AstraZeneca drug has failed to extend significantly the lives of breast cancer patients in a blow to the company’s ambitions to hit an $80bn revenue target by 2030. Datopotamab deruxtecan (Dato-DXd) is a new form of cancer treatment,
Ryan Reynolds surprises boy battling cancer
I was diagnosed with prostate cancer. My first thought was, Am I going to die? In 2005, I was inspired to go and get a ...
Radical action is needed. For only the second time in its history, the UN General Assembly will meet this week to address ...
Hydra oligactis, a freshwater creature related to jellyfish and sea anemones that is considered 'immortal' in many ways, ...
The Princess of Wales attended church with her husband and several other members of the royal family on Sunday.
Kate and Prince William were seen Sunday attending church with King Charles II and Queen Camilla near their royal Balmoral ...
20h
A snowman picking his nose made people who typically avoid informataion about colorectal cancer more likely to take a quiz ...
Scientists studying cancer in the lab often take biopsies of patients’ cancer cells to clone them. The process is ...
MIAMI — The Live Like Bella Foundation held its 11th annual Bella's Ball to honor 10-year-old Bella Rodriguez Torres and ...
Patients receiving chemotherapy in Lincolnshire can now have additional treatment to help reduce their hair loss. Many cancer ...
A new report from the American Association for Cancer Research emphasizes a cancer risk that its authors say is being ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback